Filter
1702
Text search:
national
drug
authority
Featured
132
566
Language
Document type
1083
232
203
79
57
18
16
8
2
2
1
1
Countries / Regions
98
80
70
67
47
46
44
41
41
41
35
35
35
32
31
28
26
26
23
23
22
21
19
18
17
14
14
13
10
10
10
9
9
8
7
7
6
6
6
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
846
95
73
49
36
30
24
2
Toolboxes
133
117
113
108
105
64
51
31
26
26
26
25
23
20
18
17
9
9
8
8
7
7
2
EU and Global Governance for Health - How EU global policies impact health
Ethiopia Antimicrobial Resistance Surveillance Plan
WHO/UNICEF/UNFPA joint statement
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul
...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r
...
